Bellevue Asset Management, LLC Reata Pharmaceuticals Inc Transaction History

Bellevue Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$25.61 - $110.96 $742 - $3,217	-29 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$100.0 - $143.02 $1,000 - $1,430	10 Added 52.63%	29 $3,000
Q2 2021 Aug 09, 2021	SELL	$78.27 - $151.29 $156 - $302	-2 Reduced 9.52%	19 $3,000
Q1 2021 May 12, 2021	SELL	$94.25 - $132.81 $282 - $398	-3 Reduced 12.5%	21 $2,000
Q4 2020 Feb 11, 2021	BUY	$102.03 - $184.62 $102 - $184	1 Added 4.35%	24 $3,000
Q1 2020 May 13, 2020	BUY	$124.16 - $247.74 $1,614 - $3,220	13 Added 130.0%	23 $4,000
Q4 2019 Feb 13, 2020	BUY	$74.57 - $217.92 $745 - $2,179	10 New	10 $2,000

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Bellevue Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bellevue Asset Management, LLC with notifications on news.